Trials / Unknown
UnknownNCT02033798
The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
Impact of Medical Treatment for Benign Prostatic Hyperplasia on Chronic Renal Failure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- Male
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether medical treatment for bladder outlet obstruction is effective in improvement of glomerular filtration rate and/or proteinuria.
Detailed description
Urodynamic parameters including maximal flow rate, compliance (infused volume gradient divided by bladder pressure gradient during cystometry), maximal detrusor pressure, bladder outlet obstruction index and Schäfer grade will be checked. Estimated glomerular filtration rate and urinary protein to creatinine ratio will be checked. International prostate symptom score will be checked.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin | Once Daily 0.2mg per oral for 6 months |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2016-01-01
- Completion
- 2016-06-01
- First posted
- 2014-01-13
- Last updated
- 2014-01-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02033798. Inclusion in this directory is not an endorsement.